A federal district court judge yesterday ruled that the Department of Health and Human Services would get "first crack at crafting appropriate remedial measures" to the nearly 30 percent cuts to Medicare payments affecting certain hospitals that participate in the 340B Drug Pricing Program. He also held that, like the 2018 cuts, the 2019 cuts to 340B hospitals were unlawful. The judge said that he expected HHS to “act expeditiously to resolve these issues” and required HHS to report back to him on or before Aug. 5 with its remedy proposal.
 
In a statement, the AHA, Association of American Medical Colleges and America’s Essential Hospitals said, “America’s 340B hospitals are pleased with the District Court’s decision and urge HHS to follow the judge’s directive to promptly resolve the harm caused by its unlawful cuts to Medicare reimbursement for certain 340B hospitals.” The groups also urged HHS to “promptly comply with the judge’s ruling and restore to 340B hospitals all funds that have been unlawfully withheld.” 

A federal judge Dec. 27 ruled in favor of the AHA and hospital plaintiffs that HHS's nearly 30 percent cut of 2018 Medicare payment rates for many hospitals in the 340B program was unlawful. The lawsuit was brought by the AHA, AAMC, AEH and three hospital plaintiffs.

Headline
Members of Congress and hospital and health system leaders today gathered for a briefing in Washington, D.C., to discuss how payment delays in Medicare…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Centers for Medicare & Medicaid Services May 28 issued a final rule making changes to the Increasing Organ Transplant Access Model beginning July 1.…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Perspective
Public
Approximately 35 million Americans are enrolled in Medicare Advantage plans in 2026, and that number is expected to grow to about 45 million MA enrollees by…